µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ ѧ¿Æרҵ£º ;],Js1m
)ep1`n-
´«È¾²¡Ñ§ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Oxp!G7qfo
TOb(
Ò». Ãû´Ê½âÊÍ(ÿÌâ4·Ö,¹²32·Ö) ]3\%i2NM
gTQc=,3l3
1. ICAM-1 FX
%(<M
h}U>K4BJ
2. interleukin 12(IL-12) hh[@q*C
1\X_B`xwD
3. tumor infiltrating lymphocyte .WVIdVO7
wVm
QE
4. TCR/CD3 complex xG1(vn83gq
3+/^
5. hematopoietin receptor family ,@]*Xgt=
d6XdN
6. individual idiotype(IdI) )tv~N7
vNQ|tmn
7. integrin mo D)^':.
>H,5MM!
8. colony-stimulatory factor (CSF) 6ltV}Wt-
$YiG0GK<"
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© C*stj
w
y&yK*w
1. ÃâÒßÇòµ°°×ÖØÁ´µÄ»ùÒòÈçºÎ½øÐÐÀà±ðת»»(class switching )? "!R*f $
_/NPXDL
2. ¼òÊöɱÉËÐÔTϸ°û(Tc)ɱÉ˲¡¶¾¸ÐȾ°Ðϸ°ûµÄ»úÀí¡£ U.Fs9F4M #
?P;=_~X
3. ÉúÎïÓ¦´ðµ÷½Ú¼Á( biological response modifier,BRM)Ö÷ÒªÓÐÄļ¸Àà?¼òÒª½éÉÜÔÚ´«È¾ÐÔ¼²²¡·ÀÖÎÖеÄ×÷ÓᣠHBm(l@#.
{
^R
r:+
4. ¼òÊö¿¹ÔÌá³Êϸ°û(APC)Ó븨ÖúÐÔTϸ°û(Th)Ï໥×÷ÓõĹØϵ¡£ (7C$'T-ZK
p+;;01Z+_
Èý. ÎÊ´ðÌâ(ÿÌâ18·Ö,¹²36·Ö) f{-,"6Y1
}\QXPU{UVd
1. ÊÔÊö¸ÉÈÅËصķÖÀ༰ÆäÉúÎïѧ×÷ÓÃÌص㡣Ö÷Òª¿ÉÒÔÖÎÁÆÄÄЩ´«È¾ÐÔ¼²²¡?¼òÊö¸ÉÈÅËؼì²âµÄ·½·¨ºÍÔÀí¡£ u`"Y!*[ -
d~KTUgH'<
2. ºÎΪ»ùÒò¹¤³Ì¿¹Ìå?Ä¿Ç°¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æרҵ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 1. CD4 2. T cell receptor(TCR) b
Q-n<Lx
w19OOD
3. immunoglobulin superfamily (IgSF) Q2'`K|T
Xdh@ ^`
4. selectin +4F; m_G6
F$S/zh$)0
5. anti-idiotypic antibody (¦ÁId) \Rw^&;\1
k)zBw(wr
6. major histocompatibility complex(MHC) D7Y?$=0ycb
t
$PJ*F67M
7. immunotolerance tm.&k6%
1
J[z ![Tf
8. biological reponse modifier(BRM) PHMp,z8
ypNeTR$4
9. immune reponse gene (Ir gene) i "aQm
o\qeX|.70
10. reshaped antibody (or reconstituted antibody) 4'.]-u
p
~)\!
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© Uv(}x7e)
q)PSHr=Z
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ mhF@S@
m/WDJ$d
2. ϸ°û¶¾ÐÔTÁÜ°Íϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? \}Kad\)
r<;Y4<,BZ
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ 7'5/T]Z
[-\DC*6
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? sA
}X)aP
/x/W>J2
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) ¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ 6wb M$|yFj
w_YY~Af
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? 0.#%KfQ
-./Y
2. Ä¿Ç°µ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ z]sQ3"cmX
>Lz2zlZI
¹©Ïû»¯ÄÚ¿ÆרҵÊÔÌ⣺ ltd'"J/r
)Y?E$=M+B
1. Ä¿Ç°ÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? b{W ,wn
S1!_ IK$m
2. Ä¿Ç°µ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ V{0 V/Nv
n4
Y
]v
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æרҵ: *oIKddZh
s'@@q
´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: :Czvwp{z
1xwq:vFC.
̉񧄤 ^9kdd[
NO#^_N`#\
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© ||?wRMV
tWdP5vfp
1. CD8 Sq2yQSd
uMP&.Y(
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) X .S8vlb4z
3K_!:[
3. immunoglobulin fold(Ig fold) QLTE`t5w3'
WTh|7&
4. cadherin (Ca-dependent cell adhesion moleculers) q}5&B=2pM
/XW,H0pR
5. idiotype-anti-idiotypic antibody immune network theory 4U:+iumy2
^F1zkIE
6. HLA class II antigen 9a_(_g>S
=j~}];I
7. complementarity-determining region (CDR) __||cQ
0b}lwo,|\
8. perforin(or pore-forming protein ,PFP) uO-R:MC
:hxZ2O?5_
9. high affinity IL-2 receptor w@2LFDp
v]27+/a$c
10. artificial active immunization %25_
L
jxn}):[
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© [G|2m_
`o*g2fW!
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦ÓᣠrQ$A|GJ L
f1>^kl3@P
2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 w02HSQ
^ihXM]1{G
3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£ `ionMTZY
osX23T~-
4. ÊԱȽÏT¡¢BÁÜ°Íϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃ濹ԡ¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ F]?$Q'U
*id|za|:k
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐÑ¡Ò»Ìâ,3¡¢4ÌâÖÐÑ¡Ò»Ìâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) 1. Ä¿Ç°¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ JnY3]
^! ZjK-$A<
2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨? {Q(6
.0R
.Na>BR\F
3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ W{m0z+N[B
O x$|ZEh
4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ¡¡ #-HN[U?Gs
3Yj}ra}
µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ Nyqm0C6m^
|f?C*t',
ѧ¿Æרҵ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ g&E_|}u4
47K5[R
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© lIFU7g
/l$noask
X
1. immunoglobulin gene rearrangement Ju9v n44
]VYl Eqe
2. the common chain of cytokine receptor (or a cytokine receptor subunit shared by some cytokine receptors)
B-gr2-
;W*$<~_
3. flow cytometry(FCM) eXaDx%mM
TQ2Tt"
4. carrier effect \4p<;$'
t@HE.h
5. positive selection of T lymphocytes in thymus 4 z`5W,
h B+ t
pa
6. mouse TH1(Th1) and TH2(Th2) subsets SA7,]&Zb